One Wealth Advisors LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 70.3% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,325 shares of the healthcare conglomerate's stock after selling 3,132 shares during the quarter. One Wealth Advisors LLC's holdings in UnitedHealth Group were worth $413,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Emerald Advisors LLC lifted its holdings in UnitedHealth Group by 19.4% in the second quarter. Emerald Advisors LLC now owns 1,089 shares of the healthcare conglomerate's stock valued at $340,000 after acquiring an additional 177 shares during the period. Bluesphere Advisors LLC acquired a new position in shares of UnitedHealth Group during the 2nd quarter worth $485,000. Sterling Investment Advisors Ltd. raised its stake in shares of UnitedHealth Group by 18.1% during the 2nd quarter. Sterling Investment Advisors Ltd. now owns 680 shares of the healthcare conglomerate's stock worth $212,000 after buying an additional 104 shares during the last quarter. Summit Financial Strategies Inc. raised its stake in shares of UnitedHealth Group by 23.8% during the 2nd quarter. Summit Financial Strategies Inc. now owns 1,754 shares of the healthcare conglomerate's stock worth $547,000 after buying an additional 337 shares during the last quarter. Finally, Asio Capital LLC raised its stake in shares of UnitedHealth Group by 31.0% during the 2nd quarter. Asio Capital LLC now owns 20,440 shares of the healthcare conglomerate's stock worth $6,377,000 after buying an additional 4,841 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.
Analysts Set New Price Targets
UNH has been the subject of several research reports. Morgan Stanley lifted their price target on UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a research note on Friday, September 12th. Bank of America lifted their price target on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research note on Monday, August 18th. Robert W. Baird reiterated an "underperform" rating and set a $198.00 price objective (down previously from $312.00) on shares of UnitedHealth Group in a research report on Thursday, July 31st. Piper Sandler dropped their price objective on UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Finally, KeyCorp dropped their price objective on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research report on Wednesday, July 30th. Sixteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $358.95.
Read Our Latest Research Report on UnitedHealth Group
UnitedHealth Group Stock Down 0.0%
UNH opened at $345.11 on Wednesday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a market capitalization of $312.56 billion, a price-to-earnings ratio of 14.95, a price-to-earnings-growth ratio of 2.25 and a beta of 0.45. The business has a 50-day moving average of $303.65 and a two-hundred day moving average of $357.64. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm's quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter last year, the firm earned $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.6%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group's payout ratio is currently 38.30%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.